Related Experiment Videos
Insights
Human rotavirus is a leading cause of infectious diarrhea in young children globally. Prevention strategies rely on understanding the virus
Area of Science:
- Virology
- Pediatrics
- Infectious Diseases
Background:
- Human rotavirus is a primary cause of acute infectious gastroenteritis in infants and children worldwide.
- Infection is most common in children under two years old, with peak incidence varying by geographic region.
- Rotavirus infection presents with non-specific symptoms like vomiting and diarrhea, leading to dehydration, a major cause of mortality.
Purpose of the Study:
- To review the epidemiology, clinical presentation, and current prevention strategies for human rotavirus infections.
- To highlight the importance of molecular biology in understanding rotavirus and developing effective vaccines.
- To discuss the status of ongoing rotavirus vaccine development and evaluation.
Main Methods:
- Review of existing literature on human rotavirus epidemiology and clinical manifestations.
- Analysis of studies on rotavirus molecular biology, focusing on structural proteins and antigens.
- Summary of current research on rotavirus vaccine candidates, including animal and human trials.
Main Results:
- Rotavirus infection exhibits distinct seasonality in temperate climates and occurs year-round in tropical regions.
- Dehydration is a significant complication, particularly in developing countries with common malnutrition.
- Key neutralization antigens (VP4 and VP7) have been identified, crucial for immunity.
- Several animal-derived and reassortant rotavirus vaccines are in field evaluation, with others in preclinical testing.
Conclusions:
- Understanding rotavirus molecular biology is essential for developing effective prevention strategies.
- Ongoing vaccine development shows promise for controlling rotavirus gastroenteritis globally.
- Oral rehydration therapy remains critical for managing rotavirus-induced dehydration, especially in vulnerable populations.
Abstract:
Since their discovery in the 1970s, the human rotaviruses have been recognized as the most important cause of acute infectious gastroenteritis among infants and children worldwide. Rotavirus has been found to infect almost all mammalian and avian species tested, and is primarily a disease of the young. In humans, rotavirus is the most frequent gastrointestinal pathogen in infants and children less than 2 years of age. In developing countries, the attack rate peaks at 6 months of age, whereas in developed areas of the world the virus is most commonly found among children 6-12 months of age. Rotavirus displays a marked seasonality in temperate climates, with the number of cases peaking in the colder winter months. In tropical climates, this seasonality is not as apparent, and infection may occur year round. Symptoms of rotavirus infection are non-specific and include vomiting and diarrhoea, occasionally accompanied by a low grade fever. Dehydration is more common with rotavirus infection than with most bacterial pathogens, and is the most common cause of death related to rotavirus infection. Treatment is non-specific and includes the use of oral rehydration therapy, especially in developing countries where malnutrition is common. Strategies for the prevention of rotavirus infection are dependent on advances in the understanding of the molecular biology of the rotavirus. The genetic structure of the virus has been extensively studied, and a number of the structural proteins have been identified. The neutralization antigens, located on VP4 and VP7, may be important in conferring immunity to rotavirus in vivo. Two animal-derived and several reassortant rotavirus vaccines are currently being evaluated in field studies, and a number of other candidate vaccines are being tested in vitro and in animal studies.